PRESS RELEASE published on 08/31/2026 at 22:05, 7 days 5 hours ago Inventiva Appoints Chris Benecchi as Chief Operating Officer Inventiva appoints Chris Benecchi as Chief Operating Officer to lead operational readiness for lanifibranor Phase 3 study results and potential commercialization, enhancing MASH treatment approach Chief Operating Officer Inventiva MASH Lanifibranor Chris Benecchi
PRESS RELEASE published on 08/31/2026 at 22:05, 7 days 5 hours ago Inventiva nomme Chris Benecchi au poste de Chief Operating Officer Inventiva nomme Chris Benecchi au poste de Chief Operating Officer. Chris apporte une vaste expérience dans le secteur biopharmaceutique pour soutenir le développement de thérapies innovantes Chief Operating Officer Biopharmaceutique Inventiva Lanifibranor Chris Benecchi
BRIEF published on 07/29/2026 at 22:05, 1 month 9 days ago Inventiva publie ses résultats financiers préliminaires pour le premier semestre 2026 Biopharmaceutique Des Flux De Trésorerie Inventive Dépenses De R&D Résultats Financiers 2026
BRIEF published on 07/29/2026 at 22:05, 1 month 9 days ago Inventiva Releases Preliminary Financial Results for H1 2026 Cash Flow Biopharmaceutical Inventiva R&D Expenses Financial Results 2026
PRESS RELEASE published on 07/29/2026 at 22:00, 1 month 9 days ago Inventiva annonce ses résultats financiers préliminaires pour le premier semestre 2026¹ Inventiva annonce des résultats financiers préliminaires pour le premier semestre 2026, avec trésorerie de 166,1 millions d'euros. Prévoit financement jusqu'au T2 2027 Résultats Financiers Financement Trésorerie Inventiva MASH
PRESS RELEASE published on 07/29/2026 at 22:00, 1 month 9 days ago Inventiva Announces Preliminary Financial Results for the First Half of 2026¹ Inventiva reports preliminary financial results for the first half of 2026, including cash and short-term deposits, operating activities, investing activities, and financing activities Financial Results Inventiva Investing Activities Cash Equivalents Operating Activities
BRIEF published on 07/02/2026 at 22:05, 2 months 5 days ago Inventiva's Shareholders' Meeting Approves Key Resolutions Share Capital Voting Results Shareholders' Meeting Resolutions Inventiva
BRIEF published on 07/02/2026 at 22:05, 2 months 5 days ago L'assemblée générale des actionnaires d'Inventiva approuve des résolutions clés Capital Social Resolutions Assemblée Générale Des Actionnaires Résultats Du Vote Inventive
BRIEF published on 07/02/2026 at 22:05, 2 months 5 days ago Adoption of resolutions at the Inventiva General Meeting Shareholders Biopharmaceutical Resolutions General Assembly Inventiva
BRIEF published on 07/02/2026 at 22:05, 2 months 5 days ago Adoption des résolutions à l'Assemblée Générale d'Inventiva Actionnaires Assemblée Générale Biopharmaceutique Resolutions Inventiva
Published on 09/08/2026 at 01:45, 1 hour 45 minutes ago Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 2 days 23 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 4 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 4 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 5 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/07/2026 at 19:19, 8 hours 10 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained
Published on 09/07/2026 at 19:00, 8 hours 30 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026
Published on 09/07/2026 at 18:42, 8 hours 47 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/07/2026 at 18:00, 9 hours 30 minutes ago E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Published on 09/07/2026 at 17:45, 9 hours 45 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 09/07/2026 at 19:00, 8 hours 30 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 8 hours 30 minutes ago Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 9 hours 25 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 9 hours 25 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026
